動物用薬剤市場レポート：製品、動物タイプ、投与経路、流通チャネル、地域別、2025年～2033年

世界の動物用薬剤の市場規模は2024年に374億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに604億米ドルに達し、2025年から2033年にかけて5.47%の成長率（CAGR）を示すと予測しています。ペットの飼育数の増加、診断と治療における大幅な技術進歩、家畜の食品安全と疾病管理に対するニーズの高まり、動物の健康を促進する政府の取り組み、この分野における継続的な研究開発、生産動物と伴侶動物の両方における獣医学的ケアの需要は、市場を推進する主な要因の一部です。

動物用薬剤は、動物の健康と福祉に焦点を当てた医学の専門分野です。様々な動物種の疾病、傷害、障害の診断、治療、予防を含みます。動物の健康、福祉、公衆衛生の促進に重要な役割を果たします。動物用薬剤の訓練を受けた専門家である獣医師は、家庭のペット、家畜、野生動物、実験動物などの動物に医療を提供する責任を担っています。徹底的な検査、診断テスト、薬の処方、手術、ワクチン接種などの予防医療を行います。動物用薬剤の分野は、内科学、外科学、皮膚科学、放射線学、病理学、歯科学など、さまざまな分野に及んでいます。獣医師は、ペットの飼い主、畜産農家、動物園の飼育係、その他の動物産業の専門家たちと密接に協力し、世話をしている動物たちの健康を守っています。

特に都市部におけるペット飼育の動向の高まりが、動物用薬剤の需要を牽引しています。ペットの飼い主は、定期検診、ワクチン接種、ヘルスケアの必要性から獣医サービスを求める傾向が強まっており、市場の成長に拍車をかけています。さらに、動物福祉や予防医療が重視されるようになり、動物に対する医療の重要性に対する認識が高まっています。ペットの飼い主や畜産農家は、動物の全体的な健康と幸福を確保するために、定期的に獣医の診察を受けることの重要性を認識しています。このほか、動物から人へ感染する人獣共通感染症が近年大きな注目を集めています。さらに、鳥インフルエンザやCOVID-19のような疾病の発生は、このような疾病を予防・制御する効果的な動物用薬剤の必要性を浮き彫りにし、動物衛生への投資の増加につながりました。これに加えて、肉や乳製品、その他の動物由来の食品に対する需要の高まりが、畜産における動物用薬剤の必要性を高めています。家畜の健康と福祉を確保することは、食品安全基準を維持し、高まる消費者の需要に応えるために極めて重要です。これに加えて、画像診断、実験室検査、手術技術などの獣医学技術の進歩により、動物の病気の診断と治療が大幅に改善されました。さらに、動物の健康と福祉を目的とした政府の規制やイニシアチブは、市場の形成に重要な役割を果たしています。

動物用薬剤市場動向と促進要因：

ペット飼育の増加

ペット飼育の増加傾向は市場の重要な促進要因です。ペットを飼うことを選択する人が増えるにつれて、それに伴って獣医療サービスの需要も増加します。ペットの飼い主は、毛皮で覆われた仲間の健康と幸福を確保するために、定期的な獣医療の重要性をますます認識するようになっています。予防接種、定期検診、ノミやダニ、歯の病気といった一般的な症状の治療といった予防措置を求めるようになっています。このような獣医療サービスに対する需要の高まりは、動物用薬剤に特化したクリニック、病院、製薬会社にビジネスチャンスをもたらしています。さらに、ペットの飼い主と動物との間の感情的な絆が、動物のヘルスケアへの投資意欲を駆り立て、市場のさらなる成長につながります。

技術の進歩

技術の進歩は動物用薬剤の分野に革命をもたらし、市場の成長を促進しています。デジタルX線撮影や超音波診断などの画像診断の革新は、より正確でタイムリーな診断を可能にします。高度な臨床検査法により、より迅速で正確な疾患の特定が可能になります。低侵襲手術やレーザー手術などの手術技術は、患者の転帰を改善し、回復時間を短縮しています。このような技術の進歩は、治療の質を高めるだけでなく、獣医療サービスに対する需要を増大させる。こうした技術を導入する動物病院は競争力を高め、動物に最先端の治療を求める多くの顧客を惹きつける。

家畜生産と食品の安全性

畜産における動物用薬剤の需要は、動物の健康、福祉、食品の安全を確保する必要性によってもたらされます。世界人口の増加と食肉消費量の増加に伴い、畜産農家は動物由来の食品の需要を満たすという課題に直面しています。家畜の健康と生産性を維持する上で、動物病院は極めて重要な役割を果たしています。定期的な獣医学的ケア、疾病予防プログラム、適切な管理方法は、より高品質な製品に貢献し、食中毒のリスクを低減します。食品の安全性や動物の倫理的扱いに関する消費者の関心は、畜産業におけるしっかりとした獣医医療の必要性をさらに強調しています。その結果、動物用薬剤と動物の健康管理への投資は増え続け、市場の拡大を支えています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の動物用薬剤市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品別

• 薬
  • 主要セグメント
    • 抗感染性
    • 抗炎症
    • 寄生虫駆除剤
• ワクチン
  • 主要セグメント
    • 不活化ワクチン
    • 弱毒化ワクチン
    • 組み換えワクチン
• 医薬品飼料添加物
  • 主要セグメント
    • アミノ酸
    • 抗生物質

第7章 市場内訳：動物タイプ別

• 生産
• コンパニオン

第8章 市場内訳：投与経路別

• 経口
• 非経口
• 外用

第9章 市場内訳：流通チャネル別

• 動物病院と診療所
• ポイントオブケア検査/施設内検査
• その他

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第11章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Archer-Daniels-Midland Company
  • Boehringer Ingelheim GmbH
  • Cargill Incorporated
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Merck & Co. Inc.
  • Neogen Corporation
  • Vetoquinol S.A.
  • Virbac
  • Zoetis Inc.

List of Figures

• Figure 1: Global: Veterinary Medicine Market: Major Drivers and Challenges
• Figure 2: Global: Veterinary Medicine Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Veterinary Medicine Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Veterinary Medicine Market: Breakup by Product (in %), 2024
• Figure 5: Global: Veterinary Medicine Market: Breakup by Animal Type (in %), 2024
• Figure 6: Global: Veterinary Medicine Market: Breakup by Route of Administration (in %), 2024
• Figure 7: Global: Veterinary Medicine Market: Breakup by Distribution Channel (in %), 2024
• Figure 8: Global: Veterinary Medicine Market: Breakup by Region (in %), 2024
• Figure 9: Global: Veterinary Medicine (Drugs) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Veterinary Medicine (Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Veterinary Medicine (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Veterinary Medicine (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Veterinary Medicine (Medicated Feed Additives) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Veterinary Medicine (Medicated Feed Additives) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Veterinary Medicine (Production) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Veterinary Medicine (Production) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Veterinary Medicine (Companion) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Veterinary Medicine (Companion) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Veterinary Medicine (Oral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Veterinary Medicine (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Veterinary Medicine (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Veterinary Medicine (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Veterinary Medicine (Topical) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Veterinary Medicine (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Veterinary Medicine (Veterinary Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Veterinary Medicine (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Veterinary Medicine (Point-of-Care Testing/In-house Testing) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Veterinary Medicine (Point-of-Care Testing/In-house Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Veterinary Medicine (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Veterinary Medicine (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: North America: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: North America: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: United States: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: United States: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Canada: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Canada: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Asia-Pacific: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Asia-Pacific: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: China: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: China: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Japan: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Japan: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: India: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: India: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: South Korea: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: South Korea: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Australia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Australia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Indonesia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Indonesia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Europe: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Europe: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Germany: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Germany: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: France: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: France: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: United Kingdom: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: United Kingdom: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Italy: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Italy: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Spain: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Spain: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: Russia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: Russia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 69: Latin America: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 70: Latin America: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Brazil: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 72: Brazil: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 73: Mexico: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 74: Mexico: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 75: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 76: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 77: Middle East and Africa: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
• Figure 78: Middle East and Africa: Veterinary Medicine Market: Breakup by Country (in %), 2024
• Figure 79: Middle East and Africa: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 80: Global: Veterinary Medicine Industry: SWOT Analysis
• Figure 81: Global: Veterinary Medicine Industry: Value Chain Analysis
• Figure 82: Global: Veterinary Medicine Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Veterinary Medicine Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Veterinary Medicine Market Forecast: Breakup by Product (in Million USD), 2025-2033
• Table 3: Global: Veterinary Medicine Market Forecast: Breakup by Animal Type (in Million USD), 2025-2033
• Table 4: Global: Veterinary Medicine Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
• Table 5: Global: Veterinary Medicine Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 6: Global: Veterinary Medicine Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 7: Global: Veterinary Medicine Market: Competitive Structure
• Table 8: Global: Veterinary Medicine Market: Key Players

The global veterinary medicine market size reached USD 37.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 60.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. The increasing pet ownership, significant technological advancements in diagnostics and treatments, rising need for food safety and disease control in livestock, government initiatives promoting animal health, and ongoing research and development in the field and the demand for veterinary care in both production and companion animals are some of the major factors propelling the market.

Veterinary medicine is a specialized branch of medical science that focuses on the health and well-being of animals. It encompasses the diagnosis, treatment, and prevention of diseases, injuries, and disorders in various animal species. It plays a crucial role in promoting animal health, welfare, and public health. Veterinarians, trained professionals in veterinary medicine, are responsible for providing medical care to animals, including domestic pets, livestock, wildlife, and laboratory animals. They conduct thorough examinations, perform diagnostic tests, prescribe medications, perform surgeries, and provide preventive care such as vaccinations. The field of veterinary medicine encompasses various disciplines, including internal medicine, surgery, dermatology, radiology, pathology, and dentistry. Veterinarians work closely with pet owners, livestock farmers, zookeepers, and other professionals in the animal industry to ensure the well-being of animals under their care.

The rising trend of pet ownership, particularly in urban areas, is driving the demand for veterinary medicine. Pet owners are increasingly seeking veterinary services for routine check-ups, vaccinations, and healthcare needs, thus fueling the growth of the market. Additionally, there is a greater emphasis on animal welfare and preventive care, leading to increased awareness regarding the importance of medicine for animals. Pet owners and livestock farmers are recognizing the significance of regular veterinary visits to ensure the overall health and well-being of their animals. Other than this, zoonotic diseases, which can be transmitted from animals to humans, have gained significant attention in recent years. Furthermore, the outbreak of diseases like avian influenza and COVID-19 have highlighted the need for effective veterinary medicine to prevent and control such diseases, leading to increased investments in animal health. Besides this, the growing demand for meat, dairy products, and other animal-derived food products has increased the need for veterinary medicine in livestock production. Ensuring the health and well-being of farm animals is crucial for maintaining food safety standards and meeting the rising consumer demand. Besides this, advancements in veterinary technology, such as diagnostic imaging, laboratory testing, and surgical techniques, have significantly improved the diagnosis and treatment of animal diseases. Moreover, government regulations and initiatives aimed at animal health and welfare play a vital role in shaping the market.

Veterinary Medicine Market Trends/Drivers:

Increasing pet ownership

The increasing trend of pet ownership is a significant driver of the market. As more people choose to have pets, the demand for veterinary services rises accordingly. Pet owners are increasingly aware of the importance of regular veterinary care to ensure the health and well-being of their furry companions. They seek preventive measures such as vaccinations, regular check-ups, and treatments for common conditions like fleas, ticks, and dental problems. This growing demand for veterinary services creates opportunities for clinics, hospitals, and pharmaceutical companies specializing in veterinary medicine. Additionally, the emotional bond between pet owners and their animals drives the willingness to invest in their healthcare, leading to further market growth.

Technological advancements

Technological advancements have revolutionized the field of veterinary medicine, driving market growth. Innovations in diagnostic imaging, such as digital radiography and ultrasound, enable more accurate and timely diagnoses. Advanced laboratory testing methods allow for quicker and more precise identification of diseases. Surgical techniques, including minimally invasive procedures and laser surgery, have improved patient outcomes and reduced recovery times. These technological advancements not only enhance the quality of care but also increase the demand for veterinary services. Veterinary practices that adopt these technologies gain a competitive edge and attract a larger client base seeking state-of-the-art care for their animals.

Livestock production and food safety

The demand for veterinary medicine in livestock production is driven by the need to ensure animal health, welfare, and food safety. With the increasing global population and rising meat consumption, livestock farmers face the challenge of meeting the demand for animal-derived food products. It plays a crucial role in maintaining the health and productivity of livestock. Regular veterinary care, disease prevention programs, and proper management practices contribute to higher-quality products and reduce the risk of foodborne illnesses. Consumer concerns regarding food safety and the ethical treatment of animals further emphasize the need for robust veterinary healthcare in the livestock industry. As a result, investments in veterinary medicine and animal health management continue to grow, supporting the expansion of the market.

Veterinary Medicine Industry Segmentation:

Breakup by Product:

• Drugs
• Anti-infective
• Anti-inflammatory
• Parasiticide
• Vaccines
• Inactivated Vaccines
• Attenuated Vaccines
• Recombinant Vaccines
• Medicated Feed Additives
• Amino Acids
• Antibiotics

Drugs play a crucial role in the treatment and management of animal diseases and conditions. Veterinary drugs include a wide range of pharmaceutical products such as antibiotics, anti-inflammatory drugs, antiparasitics, analgesics, and hormonal therapies. These drugs are specifically formulated and approved for use in animals to address various health issues. The market for veterinary drugs is driven by the need for effective treatment options, advancements in drug development, and the growing prevalence of animal diseases.

Vaccines stimulate an immune response in animals, providing protection against specific diseases. Veterinary vaccines help prevent the spread of infectious diseases and reduce the severity of outbreaks in animals. They are used in both companion animals and livestock, contributing to the overall health and well-being of the animal population. The demand for veterinary vaccines is driven by increased awareness of preventive healthcare, government regulations promoting vaccination programs, and the focus on disease control in animal populations.

Medicated feed additives are substances added to animal feed to deliver specific medications or nutritional supplements. These additives can contain drugs, vitamins, minerals, or other bioactive compounds to improve animal health, enhance growth performance, or prevent and control diseases. Medicated feed additives are commonly used in livestock production, where they contribute to optimized feed efficiency, disease prevention, and overall animal well-being. The market for medicated feed additives is driven by the demand for improved feed quality, the need for efficient disease prevention in large-scale farming, and the emphasis on maximizing productivity in the livestock industry.

Breakup by Animal Type:

• Production
• Companion

Production holds the largest share in the market

The market for production animals encompasses livestock and poultry, including cattle, swine, poultry, sheep, and fish. These animals are primarily raised for meat, milk, eggs, and other animal-derived products. The veterinary care for production animals focuses on disease prevention, herd health management, reproductive health, and nutrition. The market for production animals is driven by the increasing global demand for animal protein, advancements in livestock farming practices, the need to ensure food safety, and the emphasis on sustainable and efficient production methods.

The market for companion animals includes domestic pets such as dogs, cats, and exotic pets like birds, reptiles, and small mammals. Companion animal care encompasses a wide range of veterinary services, including preventive care, vaccinations, routine check-ups, dental care, and treatment for various health conditions. The market for companion animals is driven by the growing pet ownership trends, increased awareness of pet health and well-being, the emotional bond between pet owners and their animals, and the demand for high-quality veterinary care, diagnostics, medications, and pet products. The focus on pet health and the willingness to invest in their care contribute to the growth of this segment of the market.

Breakup by Route of Administration:

• Oral
• Parenteral
• Topical

Parenteral dominates the market

Oral administration refers to the delivery of veterinary medications or treatments through the oral route, typically in the form of tablets, capsules, liquids, or feed additives. Oral administration is commonly used in veterinary medicine due to its convenience and ease of use. It allows for controlled dosing, long-lasting effects, and can be administered directly by the animal owner or mixed with food. The market for oral administration products in veterinary medicine is driven by the wide range of oral medications available, the preference for non-invasive administration methods, and the need for medications that can be easily administered to animals at home or on farms.

Parenteral administration involves the delivery of veterinary medications or treatments through routes other than the digestive tract, such as injections (intravenous, intramuscular, subcutaneous), infusions, or implantations. Parenteral administration allows for rapid absorption and immediate effect, making it suitable for emergencies, critical conditions, or situations where precise dosing is required. The market for parenteral administration products in veterinary medicine is driven by the need for fast-acting medications, the ability to administer drugs in a controlled and accurate manner, and the demand for injectable vaccines, antibiotics, anesthetics, and other treatments in both production and companion animals.

Topical administration involves the application of veterinary medications or treatments directly to the skin or mucous membranes of animals. This can include ointments, creams, sprays, powders, or spot-on treatments. Topical administration is commonly used for localized treatment of skin conditions, external parasites, wound care, or eye and ear ailments. It offers localized therapeutic effects, ease of application, and reduced systemic side effects. The market for topical administration products in veterinary medicine is driven by the demand for dermatological treatments, flea and tick control products, wound management solutions, and other topical medications for both companion and production animals.

Breakup by Distribution Channel:

• Veterinary Hospitals and Clinics
• Point-of-Care Testing/In-house Testing
• Others

Veterinary hospitals and clinics represent the largest distribution channel

Veterinary hospitals and clinics serve as primary points of care for animals, providing a wide range of veterinary services, including examinations, diagnostics, treatments, surgeries, and preventive care. They have well-equipped laboratories, pharmacy services, and access to a variety of veterinary medications and products. Veterinary hospitals and clinics play a vital role in the distribution of prescription medications, specialized diets, and other veterinary products. They often have established relationships with pharmaceutical companies and distributors to ensure the availability of a diverse range of veterinary medications and supplies.

Point-of-care testing, also known as in-house testing, refers to diagnostic tests conducted on-site at veterinary clinics or hospitals. These tests allow for rapid and immediate results, enabling veterinarians to make timely treatment decisions. Point-of-care testing encompasses various diagnostic methods, including blood tests, urine tests, imaging technologies, and molecular diagnostics. The market for point-of-care testing is driven by the increasing demand for quick and accurate diagnoses, convenience, and the ability to provide immediate care to animals. Veterinary clinics and hospitals invest in point-of-care testing equipment and kits to enhance their diagnostic capabilities and offer comprehensive veterinary services in a timely manner.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for veterinary medicines.

North America comprises the United States and Canada, which have well-established veterinary healthcare systems and a large population of both companion and production animals. The market in North America is driven by factors such as the increasing pet ownership, rising demand for quality animal healthcare, advancements in veterinary technology, and a strong focus on animal welfare. The region has a well-developed network of veterinary hospitals, clinics, and specialized veterinary care providers. Additionally, there is significant investment in research and development, leading to the introduction of new veterinary drugs, vaccines, and diagnostic tools. North America also has stringent regulations regarding animal health and welfare, driving the demand for veterinary products and services.

Europe represents a substantial market for veterinary medicine, encompassing countries such as the United Kingdom, Germany, France, and Italy. The market in Europe is driven by factors such as a large population of companion animals, a strong focus on preventive healthcare, stringent regulatory standards, and a high level of pet ownership. European countries have well-established veterinary healthcare systems, with a wide network of veterinary clinics, hospitals, and specialized centers. The region emphasizes the importance of vaccination programs, disease control, and public health concerns related to zoonotic diseases. Additionally, Europe is witnessing advancements in veterinary technology, research collaborations, and investments in innovative treatment modalities, further driving the market growth.

The Asia Pacific region represents a rapidly growing market for veterinary medicine. The region comprises countries such as China, Japan, India, Australia, and emerging economies in Southeast Asia. The market in Asia Pacific is driven by factors such as the increasing disposable income, urbanization, rising pet ownership, and growing demand for animal-derived food products. Asia Pacific has a large population of both companion and production animals, contributing to the demand for veterinary services. The region also witnesses the rising adoption of Western veterinary practices and an increasing focus on animal welfare and preventive healthcare. With the expansion of the middle class and the evolving livestock industry, there is a growing need for advanced veterinary products, diagnostic tools, vaccines, and medications. The market in Asia Pacific is supported by investments in veterinary infrastructure, research and development, and government initiatives promoting animal health and welfare.

Competitive Landscape:

Key players invest significantly in research and development to innovate and introduce new veterinary drugs, vaccines, diagnostic tools, and treatment modalities. R&D efforts focus on enhancing the efficacy, safety, and convenience of veterinary products, as well as developing novel therapies for animal health conditions. Companies collaborate with research institutions and veterinary experts to stay at the forefront of advancements in the field. Additionally, key players strive to expand their product portfolios by acquiring or licensing new products, technologies, or intellectual property rights. This allows them to offer a comprehensive range of veterinary medications, vaccines, diagnostics, nutritional supplements, and other healthcare products. Other than this, key players aim to penetrate new markets and expand their geographic presence to leverage untapped opportunities. This involves establishing partnerships, distribution agreements, or acquiring local companies to gain access to new customer bases and distribution networks. Besides this, key players in the market engage in collaborations and partnerships with veterinary clinics, hospitals, research institutions, and universities. These collaborations aim to drive product development, conduct clinical trials, and expand market reach. Moreover, they invest in marketing and promotional activities to create awareness about their products and services. They employ various channels, including digital marketing, conferences, veterinary events, and educational programs, to reach veterinarians, pet owners, and livestock farmers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Archer-Daniels-Midland Company
• Boehringer Ingelheim GmbH
• Cargill Incorporated
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Evonik Industries AG
• Merck & Co. Inc.
• Neogen Corporation
• Vetoquinol S.A.
• Virbac
• Zoetis Inc.

Recent Developments:

In April 2022, Elanco Animal Health Incorporated, a leading global animal health company, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the launch of BiomEdit, a microbiome innovation company that is expected to discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines and microbial monitoring services for animal health..

Ceva Sante Animale, acquired Artemis Technologies Inc., this strategic move allows Ceva Sante Animale to enhance its portfolio of products dedicated to combating rabies in animals.

Archer-Daniels-Midland Company recently acquired a license for Gnubiotics AMOBIOME, a cutting-edge technology for use in pet food and supplement formulas. Gnubiotics AMOBIOME is a unique prebiotic that targets specific beneficial bacteria in the gut microbiome of animals.

Key Questions Answered in This Report

• 1.What was the size of the global veterinary medicine market in 2024?
• 2.What is the expected growth rate of the global veterinary medicine market during 2025-2033?
• 3.What are the key factors driving the global veterinary medicine market?
• 4.What has been the impact of COVID-19 on the global veterinary medicine market?
• 5.What is the breakup of the global veterinary medicine market based on the animal type?
• 6.What is the breakup of the global veterinary medicine market based on the route of administration?
• 7.What is the breakup of the global veterinary medicine market based on the distribution channel?
• 8.What are the key regions in the global veterinary medicine market?
• 9.Who are the key players/companies in the global veterinary medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Veterinary Medicine Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Drugs
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Anti-infective
    • 6.1.2.2 Anti-inflammatory
    • 6.1.2.3 Parasiticide
  • 6.1.3 Market Forecast
• 6.2 Vaccines
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Inactivated Vaccines
    • 6.2.2.2 Attenuated Vaccines
    • 6.2.2.3 Recombinant Vaccines
  • 6.2.3 Market Forecast
• 6.3 Medicated Feed Additives
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 Amino Acids
    • 6.3.2.2 Antibiotics
  • 6.3.3 Market Forecast

7 Market Breakup by Animal Type

• 7.1 Production
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Companion
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

• 8.1 Oral
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Parenteral
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Topical
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

• 9.1 Veterinary Hospitals and Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Point-of-Care Testing/In-house Testing
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Archer-Daniels-Midland Company
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Boehringer Ingelheim GmbH
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Cargill Incorporated
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 SWOT Analysis
  • 15.3.4 Ceva Sante Animale
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Dechra Pharmaceuticals PLC
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
  • 15.3.6 Elanco Animal Health Incorporated
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
  • 15.3.7 Evonik Industries AG
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
  • 15.3.8 Merck & Co. Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
  • 15.3.9 Neogen Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Vetoquinol S.A.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
  • 15.3.11 Virbac
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis
  • 15.3.12 Zoetis Inc.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis